Raynara Bolcont
Psychologist and researcher
Data updated
Papers
Trials
Research Footprint
Raynara Bolcont appears in 5 tracked papers (2024–2026), most studied alongside DMT, Placebo and Psilocybin, across Healthy Volunteers, Depressive Disorders and Anxiety Disorders.
Most-cited paper: Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression (27 citations).
Frequent co-authors: Fernanda Palhano-Fontes, Isabel Wießner and Handersson Barros.
Background & Research
Raynara Bolcont appears in author lists for several DMT studies spanning safety, tolerability, subjective effects, and antidepressant outcomes. Sources identify her as a psychologist trained at the Federal University of Rio Grande do Norte (UFRN) and associated with the Center for Advanced Medical Psychedelics (CAMP) in Natal, Brazil.
Key Impact
She is a coauthor on multiple recent DMT clinical and mechanistic studies, indicating active involvement in psychedelic research at the Federal University of Rio Grande do Norte.
Collaboration Network
11 collaborators· click a node to visit their profile
Full network →